FMNL3

FMNL3 is a formin-family actin assembly factor that builds filopodia and other actin-based protrusions and integrates them with cytoskeletal organization during cell migration, adhesion, and tissue morphogenesis (PMID:20862687, PMID:25428984). Its FH2 domain maintains barbed-end attachment to drive filopodial elongation, and a barbed-end-binding mutation abolishes filopodia assembly; full-length protein shows reduced activity relative to FH1-FH2 constructs, consistent with autoinhibition by accessory domains (PMID:20862687). A C-terminal WH2-like sequence binds actin monomers and barbed ends and, as a dimer, accelerates polymerization while inhibiting barbed-end elongation, with a cluster of C-terminal basic residues required for polymerization enhancement (PMID:22094460). N-myristoylation at Gly2 anchors FMNL3 to the plasma membrane, where the endogenous protein concentrates as puncta at filopodial tips, membrane ruffles, and nascent cell-cell adhesions, and is the dominant tip-localizing elongation factor for filopodia (PMID:22790947, PMID:25428984, PMID:30373894). FMNL3 is activated by GTP-bound Cdc42 and the related GTPase RhoJ: downstream of BMP/Arhgef9b signaling Cdc42 stimulates FMNL3 to nucleate endothelial filopodia during angiogenic sprouting, FMNL3 aligns stabilized microtubules into parallel arrays during endothelial elongation, and FMNL3 with RhoJ organizes radiating actin cables at the apical membrane initiation site to direct podocalyxin trafficking during vascular lumenogenesis (PMID:25584797, PMID:22275430, PMID:26299518). Beyond protrusion assembly, FMNL3 interacts with the actin-bundling protein FASCIN to control cytoplasmic actin required for meiotic spindle migration and polar body extrusion in oocytes (PMID:32167535). In cancer, FMNL3 stabilizes the EMT transcription factor Twist1 by blocking Rad23B-mediated ubiquitination, thereby reinforcing CDH1 (E-cadherin) repression and promoting migration and invasion, in a reciprocal loop in which Twist1 transactivates the FMNL3 promoter (PMID:39582466).

1. 2010 High

   Established that FMNL3 drives filopodia through its FH2 domain via barbed-end binding, defining its core actin-assembly mechanism and hinting at autoinhibitory regulation.

   Evidence Domain-swap chimeras and barbed-end-binding point mutants overexpressed in multiple cell types with fluorescence microscopy

   PMID:20862687

   Open questions at the time

   • Did not resolve how the GBD/DID/DAD domains mediate autoinhibition or relief
   • No reconstitution of full-length protein activity
2. 2011 High

   Defined a biochemically distinct C-terminal WH2-like module that binds actin monomers and barbed ends and tunes polymerization, separating actin-binding from polymerization-enhancing activities.

   Evidence In vitro actin polymerization and barbed-end elongation assays with targeted mutagenesis of the C-terminal domain

   PMID:22094460

   Open questions at the time

   • How the WH2-like C terminus cooperates with the FH2 domain in the intact protein is unresolved
   • Physiological relevance of barbed-end inhibition not tested in cells
3. 2012 High

   Linked FMNL3 to angiogenesis and showed it couples actin assembly to microtubule organization, extending its role beyond filopodia to directional cell elongation.

   Evidence siRNA knockdown in endothelial cells and morpholino knockdown with human FMNL3 rescue in zebrafish, plus microtubule immunofluorescence

   PMID:22275430

   Open questions at the time

   • Direct molecular basis for microtubule alignment not identified
   • Whether FMNL3 binds microtubules directly is unknown
4. 2012 Medium

   Identified N-myristoylation at Gly2 as the membrane-targeting requirement that licenses FMNL3's morphogenic activity.

   Evidence Gly2Ala mutagenesis and pharmacological N-myristoylation inhibition with immunofluorescence in HEK293T cells

   PMID:22790947

   Open questions at the time

   • Single-lab evidence not independently replicated
   • Interplay between myristoylation and GTPase activation not addressed
5. 2014 High

   Localized endogenous FMNL3 to plasma-membrane puncta at filopodia and nascent cell-cell adhesions, establishing a role in adhesion-specialized protrusions rather than only migration.

   Evidence Endogenous immunofluorescence, live GFP imaging, FRAP, and siRNA knockdown with filopodia counting and adhesion assays

   PMID:25428984

   Open questions at the time

   • Molecular partners at cell-cell adhesions not identified
   • Mechanism of endocytic FMNL3 puncta recycling unclear
6. 2015 High

   Placed FMNL3 in a signaling pathway by showing Cdc42 activates it downstream of BMP/Arhgef9b to build endothelial filopodia in vivo.

   Evidence Genetic epistasis in zebrafish with binding assays and live imaging

   PMID:25584797

   Open questions at the time

   • Structural basis of Cdc42-mediated activation not defined
   • How autoinhibition is relieved by GTPase binding not shown
7. 2015 Medium

   Extended GTPase regulation to RhoJ and connected FMNL3 to apical actin organization and podocalyxin trafficking during lumen formation.

   Evidence Co-IP of FMNL3 with Cdc42 and RhoJ, localization, and siRNA/shRNA knockdown with podocalyxin trafficking readout in endothelial cells

   PMID:26299518

   Open questions at the time

   • Whether RhoJ activates FMNL3 like Cdc42 not directly tested
   • Mechanism linking actin cables to vesicular trafficking unresolved
8. 2018 Medium

   Quantitatively established FMNL3 as the dominant tip-localizing filopodial elongation factor, distinguishing it from Ena/VASP proteins.

   Evidence Comparative siRNA knockdown of FMNL3, VASP, and Mena with quantitative tip imaging in U2OS cells

   PMID:30373894

   Open questions at the time

   • Context-dependence beyond U2OS cells not established
   • Functional cooperation with focal adhesions mechanistically undefined
9. 2020 Medium

   Revealed a FASCIN-dependent function for FMNL3 in regulating cytoplasmic actin for meiotic spindle migration, broadening its roles beyond protrusion assembly.

   Evidence Depletion in mouse oocytes, FMNL3-FASCIN Co-IP, and mRNA rescue with immunofluorescence

   PMID:32167535

   Open questions at the time

   • Direct FMNL3-FASCIN binding interface not mapped
   • Single Co-IP without reciprocal structural validation
10. 2024 Medium

    Identified a non-cytoskeletal, transcription-stabilizing role in which FMNL3 protects Twist1 from Rad23B-mediated ubiquitination to drive EMT and invasion.

    Evidence Reciprocal Co-IP, ubiquitination assay, ChIP/promoter binding, and migration/invasion assays in breast cancer cells

    PMID:39582466

    Open questions at the time

    • How FMNL3 physically blocks the Twist1-Rad23B interaction is undefined
    • Whether this function requires actin-assembly activity not tested

• How FMNL3's autoinhibition is relieved by GTPase binding and membrane anchoring, and whether its cytoskeletal and Twist1-stabilizing functions are mechanistically linked, remain open.
• No structure of regulated full-length FMNL3
• No unified model linking protrusion assembly to Twist1 stabilization